Japan appears to be one of the healthiest nations. However, each step of healthcare services is not excellent while macroscopic outcomes are exceptional. Globalization is also key concept in Japanese respiratory healthcare services. As international communication between physicians become more common, the reality that various gaps in respiratory healthcare services still remain in place is becoming clearer. Now, clinicians are paying attention to global sources of information. Respiratory medicine will also change from experience-based medicine to evidence-based science. Chronic
Japan is an island country located in East Asia, far from European and American nations. Japan has traditionally been influenced enormously by China; however, medical science and healthcare services have been modelled after Western countries. This has become the foundation of the current system of health care services, which is to maintain the health of the general public. Currently, the average life span and mean life expectancy at 65 years in Japan is among the longest in the world, and the death rate and infant mortality rate are also among the lowest in the world. Japan appears to be one of the healthiest nations. However, the health is not necessary brought about by exceptional healthcare services. In other words, each step of healthcare services is not excellent while macroscopic outcomes are exceptional.
Healthcare services are mainly funded by public sources through the public health insurance system. As much as 99.3% of the country's population was covered by public health insurance in 2001. Services are provided by healthcare facilities that are mainly private. In 2000, the ratio of total medical expenditure to GDP was 13.1% in the USA, 7.6% in Japan, and 7.3% in the UK, respectively, and costs are kept low in Japan. The number of hospitals per capita is very high, and the number of staff per hospital bed is extremely low. Compared to European and American nations, a shortage of employ-ees in medical facilities is a more serious problem. Japanese healthcare service characteristics include a fee-for-service system (reimbursement on a piecework basis) and free access (patients can visit clinics whenever and wherever they like without an appointment). Although these are recognized as medical policy issues in Japan and various reform plans being proposed and modified, the Ministry of Health, Labour and Welfare has made it clear that both will be maintained in the future. The number of outpatient visits per capita and the number of outpatients seen per physician are both three to four times higher in Japan than in European and American nations, which indicates that Japanese people like hospitals and Japanese physicians have a demanding work environment.
Tuberculosis was the top cause of death between 1935 and 1950. The number of deaths due to tuberculosis decreased to 1.8 per 100 000 in 2002. The Japanese Society for Tuberculosis was established in 1923, and now has more than 3300 members.' Since it took longer in Japan to reduce the number of patients with pulmonary tuberculosis, respiratory specialists had to concentrate on treating tuberculosis patients. It is one of the reasons why respiratory specialists who treat patients with other respiratory medical conditions were slow to learn in the early years. The Japanese Respiratory Society was established in 1961, and it currently has approximately 10 000 members.2 It is the largest professional organization in respiratory medicine. The Japanese Society of Allergology, which was established in 1952, has approximately 9000 members and contributes to advancements in asthma research.3 10 2006 Edward Arnold (Publishers) Ltd Correspondence: Koichi Nishimura, Respiratory Division, 17 Yamadahirao, Nishikyo-ku, Kyoto, 615-8256, Japan. E-mail:koichi-nishimnura@nifty.com 10.1 191/1479972306cdlO6rs Globalization is also a key concept in Japanese respiratory healthcare services. For example, inhaled corticosteroids were established as the first line drug for asthma treatment in Europe. Inhaled corticosteroids were not recognized in Japan until 10-20 years later. After the National Heart, Lung, and Blood Institute first published its asthma guidelines, the author translated them into Japanese for publication. We received persistent resistance from asthma specialists at that time in Japan. Today, almost no asthma specialist in Japan criticizes Global Initiative for Asthma guidelines; however, the sale of inhaled corticosteroids per capita in Japan is approximately 10% of that in the UK. Rapid changes are seldom accepted in Japan, and reform advances slowly. In Japan, asthma mortality per 100 000 between the ages of five and 34 is 8.7. The mortality rate is definitely higher than rates from the USA (5.2), South Korea (4.9) and Canada (1.6).
Randomized controlled trials (RCT), evidence based medicine, clinical guidelines and total quality management or and quality control are some of the approaches used to render science-based healthcare services. However, these Western approaches are not popular among clinicians in Japan, and many clinicians still feel uncomfortable with these notions. RCTs are limited, and although numerous large-scale, international clinical trials have been planned and conducted in the past decade, Japanese institutes have participated in almost none. Evidence gathered in Japan is seldom cited in guidelines published in Western countries. However, Japanese guidelines on asthma and COPD (chronic obstructive pulmonary disease), community acquired pneumonia and other topics have also been published in Japan. Japanese guidelines are different from European or American guidelines since they are created by organizational representatives who have little RCT experience.
The prevalence of COPD in Western nations is 2-6%, while only a few cases of COPD are diagnosed in Japan. Calculations from the Nippon COPD Epidemiology (NICE) Study, with subjects randomly selected from a general population sample showed that 8.5% of persons over 40 have COPD, and estimated that 5 300 000 potential patients exist in Japan.4 The patient survey conducted in 1996 by the Ministry of Health, Labour and Welfare recognized only 220 000 people, which corresponds to 0.3% of persons over 40. Most COPD patients are not receiving healthcare services for COPD or receiving care for conditions other than COPD. The reason for the large gap is still unknown. More than 100 000 patients currently receive long-term domiciliary oxygen therapy. According to 1995 data,5 40% have COPD, and sequelae of pulmonary tuberculosis, chronic interstitial pneumonia, and lung cancer are the next most common diseases.
The existence of an independent department of oncology is rare, and many patients with lung cancer are assigned to the respiratory divisions of Japanese hospitals. Chemotherapeutic advancements, especially in patients with non-small cell carcinoma are recent topics, and many chemotherapeutic clinical trials are being conducted in Japan for lung cancer patients. Although the efficacy of gefitinib is still being discussed, Japan was the first to list it as a medication covered by insurance. The shared role between oncology and respiratory physicians is not necessarily clear, and this is an important issue, which needs to be resolved in the future.
In conclusion, as international communications between physicians become more common, the reality that various gaps in respiratory healthcare services still remain in place is becoming clearer. In the past, Japanese physicians followed the prevailing professional opinion in Japan and trusted decisions made by Japanese authorities. Now, clinicians are paying attention to global sources of information. Respiratory medicine will also change from experience-based medicine to evidence-based science. The general public will also prefer science-based medicine to healthcare services based on a physician's experience. At present, it may be difficult to make the transition to western approaches; however, the author believes that it is the duty of young physicians including our colleague to deliver evidence-based healthcare services, which are more commonly accepted in Western countries, in the trend of westemization in Japan.
